Compass Therapeutics, Inc.
CMPX
$2.25
-$0.01-0.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -73.45M | -68.17M | -66.49M | -65.81M | -62.03M |
| Total Depreciation and Amortization | 1.49M | 1.48M | 1.47M | 1.46M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.98M | 9.02M | 6.70M | 8.03M | 9.09M |
| Change in Net Operating Assets | 4.87M | 4.47M | 9.18M | 11.26M | 6.13M |
| Cash from Operations | -56.11M | -53.20M | -49.14M | -45.05M | -45.25M |
| Capital Expenditure | -265.00K | -89.00K | -25.00K | -25.00K | -62.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -64.82M | -66.38M | -93.28M | -74.53M | 49.68M |
| Cash from Investing | -65.08M | -66.47M | -93.31M | -74.56M | 49.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 143.13M | 143.13M | 139.27M | 138.00M | 0.00 |
| Repurchase of Common Stock | -701.00K | -701.00K | -1.03M | -911.00K | -911.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.64M | -8.64M | -8.64M | -8.64M | 0.00 |
| Cash from Financing | 133.79M | 133.79M | 129.61M | 128.45M | -911.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 568.00K | 568.00K |
| Net Change in Cash | 12.60M | 14.12M | -12.84M | 9.41M | 4.02M |